CONDENSED CONSOLIDATED INTERIM STATEMENTS OF LOSS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2025	Apr. 30, 2024	Apr. 30, 2025	Apr. 30, 2024
EXPENSES
Accretion expense	$ 63,765	$ 19,897	$ 222,460	$ 69,419
Consulting	49,769	69,472	171,659	235,655
Directors' fees	20,000	30,000	70,000	88,022
Filing and regulatory	5,341	8,959	41,261	30,545
Foreign exchange (gain) loss	360	20,081	5,773	27,980
General and administrative	72,171	76,937	197,143	339,088
Geological, mineral, and prospect costs	7,131	337,158	72,984	732,924
Interest expense	55,592	62,569	220,708	192,230
Professional fees	104,335	276,858	329,909	872,136
Promotion and shareholder communication	6,525	8,079	20,908	51,558
Salaries	0	(43)	0	89,526
Share-based compensation	59,696	0	258,415	230,985
Loss	(444,685)	(909,967)	(1,611,220)	(2,960,068)
Gain on fair value adjustment on derivative liability	0	8,742	0	137,457
Impairment of assets held for sale	(311,530)	0	(311,530)	0
Loss on note receivable	0	0	(155,727)	0
Write-off of receivable	0	40	0	(64,524)
Other income	181	8,374	7,717	18,413
Net loss and comprehensive loss for the period	$ (756,034)	$ (892,811)	$ (2,070,760)	$ (2,868,722)
Basic loss per common share	$ (0.01)	$ (0.02)	$ (0.04)	$ (0.07)
Diluted loss per common share	$ (0.01)	$ (0.02)	$ (0.04)	$ (0.07)
Weighted average number of common shares outstanding (basic) (in shares)	55,785,106	47,128,914	55,785,106	43,108,301
Weighted average number of common shares outstanding (diluted) (in shares)	55,785,106	47,128,914	55,785,106	43,108,301